Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Phase III Clinical Trial to Evaluate the Safety of 0.03% DSC127 Gel in Chronic Use for Treating Diabetic Foot Ulcers ("DFU")

NCT01840085 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT01840085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Phase III Clinical Trial to Evaluate the Safety of 0.03% DSC127 Gel in Chronic Use for Treating Diabetic Foot Ulcers ("DFU")
Lead sponsor
Integra LifeSciences Corporation
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2015
Completion date
December 31, 2015
Enrollment
261 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer